A randomised controlled trial of single-dose oral Ivermectin in patients with COVID-19 infection
Implementing Organization
All India Institute of Medical Sciences (AIIMS)
Visit
Principal Investigator
Dr Anant Mohan
Professor, All India Institute of Medical Sciences (AIIMS), New Delhi
Project Overview
This project aims to evaluate the efficacy of (1) single-dose Ivermectin in reducing viral load in COVID-19 patients, (2) Ivermectin in time with clinical improvement, the percentage of patients progressing to severe disease, and frequency of adverse events in both arms.
Professor, All India Institute of Medical Sciences (AIIMS), New Delhi
Accessibility Controls